Loss of CDK5 in breast cancer cells opens up the mitochondrial permeability transition pore (mPTP), initiating increased mitochondrial depolarization and higher ROS levels, with subsequent activation of caspases and cell death (Fig. 1B). Here, CDK5 is linked to breast carcinoma.